Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Dual fronts poised to transform melanoma therapy

Nature Reviews Drug Discovery volume 10, pages 325–326 (2011)Cite this article

Subjects

With recent successes of immunotherapies and targeted drugs, melanoma has become one of the most dynamic areas of anticancer drug development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. Dual fronts poised to transform melanoma therapy. Nat Rev Drug Discov 10, 325–326 (2011). https://doi.org/10.1038/nrd3441

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3441

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer